Tag Archives: Oren Livnat

Corium (CORI) Receives a Buy from H.C. Wainwright

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Corium (NASDAQ: CORI), with a price target of $13. The company’s shares closed on Friday at $8.65. Livnat noted: “Our $13 12-month target is based

H.C. Wainwright Sticks to Their Buy Rating for BioDelivery (BDSI)

H.C. Wainwright analyst Oren Livnat maintained a Buy rating on BioDelivery (NASDAQ: BDSI) today and set a price target of $4. The company’s shares closed yesterday at $2.90. According to TipRanks.com, Livnat has currently no stars on a ranking scale

H.C. Wainwright Remains a Hold on Jazz Pharmaceuticals (JAZZ)

H.C. Wainwright analyst Oren Livnat reiterated a Hold rating on Jazz Pharmaceuticals (NASDAQ: JAZZ) today and set a price target of $167. The company’s shares closed yesterday at $175.58, close to its 52-week high of $184. Livnat observed: “We highlighted

H.C. Wainwright Reiterates Their Buy Rating on Pacira Pharmaceuticals

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on Pacira Pharmaceuticals (NASDAQ: PCRX), with a price target of $48. The company’s shares opened today at $35.60. Livnat said: “Valuation and risks. Our $48 12-month

BioDelivery Receives a Buy from H.C. Wainwright

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on BioDelivery (NASDAQ: BDSI), with a price target of $3.50. The company’s shares opened today at $2.90. Livnat wrote: “Valuation and risks. We assume Belbuca continues

Analysts Are Bullish on These Healthcare Stocks: ZYNE, BSX

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zynerba Pharmaceuticals (NASDAQ: ZYNE) and Boston Scientific Corp (NYSE: BSX) with bullish sentiments. Zynerba Pharmaceuticals (ZYNE) In a report released today, Oren